Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated biotechnology company advancing a sustainable pipeline of ...

A live audio webcast of the events will be available under the “Investors/Events” section of the IDEAYA website at https://ir ...

Immunocore will present five-year overall survival data for KIMMTRAK during oral presentation at the 2026 AACR meeting(OXFORDSHIRE, England & ...

When a patient undergoes an organ transplant, failure to match the donor and recipient can lead to the recipient's immune system attacking the new organ, a process triggered by a specific HLA (human ...

aThe Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA bPrecision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA cIcahn Genomics ...

IDEAYA Biosciences (NASDAQ:IDYA) outlined upcoming clinical milestones for its precision oncology pipeline, emphasizing an imminent top-line readout in first-line metastatic uveal melanoma (MUM), ...

Human leukocyte antigen-G (HLA-G) has emerged as one of the most compelling regulators of immune tolerance. Initially characterized for its essential role at the maternal–fetal interface, HLA-G is now ...

Organ allocation to minimize Human Leukocyte Antigens (HLA) disparity between donor and recipient has been shown to improve outcomes but is limited by the enormous HLA diversity. PIRCHE-II in silico ...

Dr Avtar K Handa was a Keynote speaker at the Indian Horticulture Congress-2025 and International Meet on Horticulture for Inclusive, equitable and sustainable Growth. This conference was organized by ...

A study published yesterday in the peer-reviewed journal Scientific Reports finds that cannabidiol may suppress a key immune-evasion molecule used by certain tumors while simultaneously reducing their ...